1.13 USD
▲+0.07+10.78%
盘后 0.98 -3.92%
2026-08-03
市值
$4.42M
市盈率
—
EPS
-15.33
股息率
—
52 周区间
0.88 – 11.72
成交量
33.64K
Beta
-0.12
目标价
19.25
52W 低 0.8852W 高 11.72
价格走势
公司简介
Revelation Biosciences, Inc. operates as a clinical-stage life science company that focuses on the rebalancing inflammation to optimize health. The company's lead product candidate is lead product candidate Gemini, a proprietary formulation platform of phosphorylated hexaacyl disaccharide (PHAD), an established Toll-like receptor 4 (TLR) agonist that works by modulating and rebalancing a dysregulated inflammatory response. It also engages in the prevention and treatment of disease by developing and commercializing therapeutics that modulate the...